Study tracks lifesaving drug use in C-Section bleeding emergencies

NCT ID NCT07278037

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks back at medical records of 648 women who had heavy bleeding after a C-section. Researchers want to see how often the drug tranexamic acid (TXA) was given over the years, and whether more use led to better outcomes like less blood loss or fewer transfusions. The goal is to understand real-world use of a treatment that can cut death from bleeding by 31%.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
tranexamic acid (TXA)
What this could lead to
If successful, this study could confirm that wider use of TXA after C-section bleeding improves survival and reduces complications.
What could go wrong
This is a retrospective chart review, not a controlled trial, so it can't prove cause and effect. Results may not apply to all hospitals or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

perinatal disease Postpartum Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Siriraj Hospital

    RECRUITING

    Bangkoknoi, Bangkok, 10700, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.